Drug Trial Radar · NCT05507203
ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1
Last checked: Nov 19, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
639
Actual
Start
Nov 16, 2022
Primary completion
Jun 24, 2025
Study completion Jun 25, 2025
Sponsor
- Lead sponsor
- Abivax S.A.Industry
- Sponsor type
- Industry
- First posted
- Aug 18, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multicenter, randomized, placebo controlled study to evaluate the efficacy and safety of ABX464 given at 25 or 50 mg QD in inducing clinical remission in subjects with moderately to severely active ulcerative colitis who have inadequate response, no response, a loss of response, or an intolerance to either conventional therapies \[corticosteroids, immunosuppressant (i.e. azathioprine, 6-mercaptopurine, methotrexate)\] and/or advanced therapies \[biologics (TNF inhibitors, anti-integrins, anti-IL-23), and/or S1P receptor modulators, and/or JAK inhibitors\].
Conditions
- Ulcerative Colitis
Interventions
ABX464Drug
Administered once daily in the morning with food
PlaceboDrug
Administered once daily in the morning with food
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects Who Achieve Clinical Remission Per Modified Mayo Score at Week 8Time frame: 8 weeks
Locations
264 sites in 24 countries. Site status is shown where the registry gives one.
Digestive Health Specialists of the Southeast
Dothan, Alabama
Lakeview Clinical Research
Guntersville, Alabama
Birmingham Digestive Health Research
Homewood, Alabama
GI Alliance
Sun City, Arizona
Del Sol Research Management, LLC
Tucson, Arizona
Gastro Care Institute
Lancaster, California
California Medical Research Associates Inc.
Northridge, California
Clinnova Research Solutions
Orange, California
Peak Gastroenterology Associates
Colorado Springs, Colorado
Clinical Research Of Brandon, LLC
Brandon, Florida
Access Research Institute
Brooksville, Florida
Nature Coast Clinical Research - Inverness
Inverness, Florida
Auzmer Research
Lakeland, Florida
Medical Professional Clinical Research Center
Miami, Florida
Advanced Research Institute, Inc.
New Port Richey, Florida
Endoscopic Research, Inc.
Orlando, Florida
Orlando Health-Orlando Regional Medical Center
Orlando, Florida
Advanced Research Institute, Inc.
Orlando, Florida
Gastroenterology Associates of Pensacola, PA
Pensacola, Florida
Theia Clinical Research Centers, LLC
Temple Terrace, Florida
One Health Research Clinic Atlanta, LLC
Norcross, Georgia
Eagle Clinical Research
Chicago, Illinois
GI Alliance
Glenview, Illinois
GI Alliance
Gurnee, Illinois
Indiana University School of Medicine
Indianapolis, Indiana
University of Kansas Medical Center Research Institute, Inc.
Kansas City, Kansas
Lucida Clinical Trials LLC
New Bedford, Massachusetts
Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire
Rochester Clinical Research
Rochester, New York
Charlotte Gastroenterology and Hepatology, P.L.L.C
Charlotte, North Carolina
Care Access Research Lumberton
Lumberton, North Carolina
Wexner Medical Center
Columbus, Ohio
DSI Research LLC
Springboro, Ohio
Gastroenterology Center of the MidSouth PC
Germantown, Tennessee
GI Alliance - Southlake
Austin, Texas
Central Texas Clinical Research, LLC
Austin, Texas
Novel Research LLC
Bellaire, Texas
Texas Digestive Disease Consultants
Cedar Park, Texas
Baylor Scott and White
Dallas, Texas
Cook Children's Medical Center
Fort Worth, Texas
Showing 40 of 264 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.